ARWR

Q: What is the price of Arrowhead Pharmaceuticals (ARWR) today?

The price of Arrowhead Pharmaceuticals (ARWR) today is $ 69.62, with return of 267.19% compared to the last year. The price of Arrowhead Pharmaceuticals (ARWR) started the year trading around $ 18.80 and today it is at $ 69.62. Follow the real-time price chart, the historical price of Arrowhead Pharmaceuticals (ARWR) and international markets.

Q: When does Arrowhead Pharmaceuticals (ARWR) pay dividends?

Arrowhead Pharmaceuticals (ARWR) did not distribute dividends in the last year.

Q: Is Arrowhead Pharmaceuticals (ARWR) worth it?

Currently, Arrowhead Pharmaceuticals (ARWR) is priced at $ 69.62, with a P/E of -5,903.71%, representing a deviation of -119,689% from its historical average P/E. In the last year, the stock showed a variation of 267.19 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 267.19%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Arrowhead Pharmaceuticals (ARWR) stock?

Investing in stocks of Arrowhead Pharmaceuticals (ARWR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Arrowhead Pharmaceuticals (ARWR) yield today?

The yield of Arrowhead Pharmaceuticals (ARWR) was 32.11% in the last month, 267.19% in the last year and -9.27% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Arrowhead Pharmaceuticals (ARWR) today, the total investment would be $ 6,962.00, based on the current price of $ 69.62.If past performance were to repeat, the return on your investment would be:In 1 year: $ 25,563.77In 5 years: $ 6,316.62In 10 years: $ 81,052.30It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Arrowhead Pharmaceuticals Inc.

Price

$ 69.62

return (12m)

267.19%

p/e

-5,903.71

p/bv

19.23

DIVIDEND YIELD

0.00%

price ARWR

ARWR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ARWR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

32.11%

3 months

101.86%

1 year

267.19%

2 years

127.52%

5 years

-9.27%

10 years

1,064.21%

Fundamentals ARWR

review the fundamentals of Arrowhead Pharmaceuticals shares

P/E

-5,903.71

Sector: -3.69 Industry: -3.69

P/SALES RATIO (PSR)

11.67

Sector: -3.67 Industry: -3.67

P/BV

19.23

Sector: 2.06 Industry: 2.06

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-0.12%

Sector: -63.57% Industry: -63.57%

ROE

-0.33%

Sector: -66.84% Industry: -66.84%

ROIC

15.65%

Sector: -1,129.00% Industry: -1,129.00%

NET MARGIN

-0.20%

Sector: -41.13% Industry: -41.13%

GROSS MARGIN

100.00%

Sector: 39.22% Industry: 39.22%

OPERATING MARGIN

11.86%

Sector: -40.98% Industry: -40.98%

P/EBITDA

58.74

Sector: -3.65 Industry: -3.65

P/EBIT

68.72

Sector: -3.78 Industry: -3.78

P/ASSET

6.99

Sector: 1.47 Industry: 1.47

BVPS

3.65

Sector: 1.77 Industry: 1.77

EPS

-0.01

Sector: -2.04 Industry: -2.04

EQUITY RATIO

0.36

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

59.70%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-56.28%

Sector: - Industry: -

Fundamentals ARWR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.90	6.31	31.69%	2.48%	$ 499.97 B	27.26%
PFE	14.51	1.53	10.56%	6.86%	$ 142.64 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	15.11	8.72	57.70%	3.22%	$ 232.87 B	32.78%
MRK	14.01	0.00	0.00%	3.03%	$ 266.74 B	29.63%
AZN	30.66	6.27	20.45%	1.68%	$ 288.18 B	16.17%
BMY	18.42	5.98	32.47%	4.54%	$ 111.25 B	12.57%
GILD	18.99	7.18	37.80%	2.53%	$ 153.99 B	27.88%
ZTS	21.09	10.36	49.11%	1.58%	$ 55.92 B	28.21%
HALO	13.53	15.99	118.17%	0.00%	$ 8.06 B	47.91%
REGN	17.83	2.64	14.79%	0.45%	$ 81.64 B	32.13%
AMGN	25.57	18.62	72.82%	2.86%	$ 179.12 B	19.47%
MCK	25.44	-177.52	-697.75%	0.36%	$ 102.61 B	1.04%
VRTX	32.24	6.84	21.22%	0.00%	$ 118.50 B	31.35%
CAH	31.08	-18.15	-58.40%	0.98%	$ 49.57 B	0.68%
ADMA	22.00	10.69	48.57%	0.00%	$ 4.61 B	42.87%
BIIB	16.18	1.43	8.83%	0.00%	$ 26.03 B	15.98%
HRMY	11.91	2.65	22.24%	0.00%	$ 2.21 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ARWR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

Average user rating I10

4.0 (2 people)

United States

36 years

Founded: 1989

1997

Time since IPO - 28 years

232

Employees

The Company Arrowhead Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 9.68 Billions, having an equity of $ 503.42 Millions.

With a total of 232 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 829.45 Millions, which generated a loss in the amount of $ -1.64 Million.

As for its main indicators, the Company has a P/E ratio of -5,903.71, a P/BV ratio of 19.23 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ARWR.

Market cap

$ 9.68 Billions

Net worth

$ 503.42 Millions

US$ 503,420,000.00

Assets

$ 1.39 Billion

US$ 1,385,300,000.00

Total Shares Outstanding

138.00 Millions

138,000,000

Average Daily Trading Volume

$ 2.48 Millions

US$ 2,484,647.90

Sector

Health Care

Industry

Biotechnology

ARWR

ARWR revenue and profits

Financial Results ARWR

DRAG THE FRAME TO SEE MORE DATA

ARWR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 830.42 46,28% (12M)

P/E

25.44

0.36%

ROE

-697.75%

P/BV

-177.52

CAH - Cardinal Health

$ 207.38 78,83% (12M)

P/E

31.08

0.98%

ROE

-58.40%

P/BV

-18.15

JNJ - Johnson & Johnson

$ 207.56 49,24% (12M)

P/E

19.90

2.48%

ROE

31.69%

P/BV

6.31

MRK - Merck & Co.

$ 106.62 13,36% (12M)

P/E

14.01

3.03%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.00 2,81% (12M)

P/E

14.51

6.86%

ROE

10.56%

P/BV

1.53

ABBV - AbbVie

$ 230.84 36,63% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 92.52 44,11% (12M)

P/E

30.66

1.68%

ROE

20.45%

P/BV

6.27

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 830.42 46,28% (12 M)

P/L

25.44

0.36%

ROE

-697.75%

P/VP

-177.52

CAH - Cardinal Health

$ 207.38 78,83% (12 M)

P/L

31.08

0.98%

ROE

-58.40%

P/VP

-18.15

JNJ - Johnson & Johnson

$ 207.56 49,24% (12 M)

P/L

19.90

2.48%

ROE

31.69%

P/VP

6.31

MRK - Merck & Co.

$ 106.62 13,36% (12 M)

P/L

14.01

3.03%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.00 2,81% (12 M)

P/L

14.51

6.86%

ROE

10.56%

P/VP

1.53

ABBV - AbbVie

$ 230.84 36,63% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 92.52 44,11% (12 M)

P/L

30.66

1.68%

ROE

20.45%

P/VP

6.27

Frequently Asked Questions

What is the price of Arrowhead Pharmaceuticals (ARWR) today?

The price of Arrowhead Pharmaceuticals (ARWR) today is $ 69.62, with return of 267.19% compared to the last year. The price of Arrowhead Pharmaceuticals (ARWR) started the year trading around $ 18.80 and today it is at $ 69.62. Follow the real-time price chart, the historical price of Arrowhead Pharmaceuticals (ARWR) and international markets.

When does Arrowhead Pharmaceuticals (ARWR) pay dividends?

Arrowhead Pharmaceuticals (ARWR) did not distribute dividends in the last year.

Is Arrowhead Pharmaceuticals (ARWR) worth it?

Currently, Arrowhead Pharmaceuticals (ARWR) is priced at $ 69.62, with a P/E of -5,903.71%, representing a deviation of -119,689% from its historical average P/E. In the last year, the stock showed a variation of 267.19 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 267.19%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Arrowhead Pharmaceuticals (ARWR) stock?

Investing in stocks of Arrowhead Pharmaceuticals (ARWR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Arrowhead Pharmaceuticals (ARWR) yield today?

The yield of Arrowhead Pharmaceuticals (ARWR) was 32.11% in the last month, 267.19% in the last year and -9.27% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Arrowhead Pharmaceuticals (ARWR) today, the total investment would be $ 6,962.00, based on the current price of $ 69.62.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 25,563.77
In 5 years: $ 6,316.62
In 10 years: $ 81,052.30

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ARWR

Arrowhead Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of ARWR

review the fundamentals of Arrowhead Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

United States

36 years

1997

232

PROFIT X PRICE ARWR

Financial Results ARWR

ARWR cash flow

asset growth - ARWR

ARWR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions